[CAS NO. 2081072-29-7]  NEO2734

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [2081072-29-7]

Store
Catalog
SLK-S9648
Brand
Selleck
CAS
2081072-29-7

DESCRIPTION [2081072-29-7]

Overview

MDL-
Molecular Weight435.44
Molecular FormulaC22H24F3N3O3
SMILESO=C1C(C)=CC(C2=CC=C3N=C(C4CCOCC4)N(CCOC(F)(F)F)C3=C2)=CN1C

For research use only.

Storage

3 years,-20°C,powder
1 years,-80°C,in solvent

Shipping

Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

1 mg5 mg10 mg
1 mM2.2965 mL11.4826 mL22.9653 mL
5 mM0.4593 mL2.2965 mL4.5931 mL
10 mM0.2297 mL1.1483 mL2.2965 mL
50 mM0.0459 mL0.2297 mL0.4593 mL

Description

NEO2734 (EP31670) is a novel, orally active and selective dual inhibitor of and with IC50 of both <30 nM.

Targets

p300/CBP [1]
(Cell-free assay)
BET [1]
(Cell-free assay)
<30 nM<30 nM

In vitro

Treatment of NMC cells with the novel dual p300/CBP and BET bromodomain–selective inhibitor, NEO2734, potently inhibits growth and induces differentiation of NMC cells in vitro; findings that correspond with potentiated transcriptional effects from combined BET and p300 bromodomain inhibition.